MyStart Health
MyStart Health is a direct-to-consumer telehealth platform focused on affordable GLP-1 weight loss prescriptions. The company entered the compounded semaglutide market in 2024, offering budget pricing with an asynchronous consultation model. Limited public information is available about the company's founding team, headquarters, or clinical governance structure.
Overview
- Consultation Model
- Hybrid
- Headquarters
- United States
- Shipping
- 3-5 business days
- Lab Testing
- Yes
- Prescriber Info
- Licensed healthcare providers evaluate patients and prescribe based on clinical eligibility.
Pros
- Budget-friendly compounded GLP-1 pricing
- All-inclusive pricing with no hidden fees
- Fast async onboarding process
- No subscription commitment required
Cons
- Compounded medications only
- Compounded GLP-1 supply faces active FDA enforcement pressure
- Limited company transparency
- No video consultations available
- No lab testing included
- No nutrition coaching or wraparound care